Market Overview The Global Inhalation and Nasal Spray Generic Drugs Market was valued at USD 33.21 Billion in 2022 and is projected to reach USD 46.20 Billion by 2029, growing at a CAGR of 4.83% during 2023–2029. Rising prevalence of asthma, COPD, allergic rhinitis, and other respiratory conditions is increasing demand for accessible inhalation and nasal therapies. At...